Cocoa polyphenols and soluble dietary fiber for use in the treatment or prevention disorders associated with an above-normal number of granulocytes in a tissue

US2019008824A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2019008824-A1
Application numberUS-201615780490-A
CountryUS
Kind codeA1
Filing dateDec 1, 2016
Priority dateDec 4, 2015
Publication dateJan 10, 2019
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a composition comprising at least one cocoa polyphenol and soluble dietary fiber for use in the prevention or treatment of a disorder associated with an above-normal number of granulocytes in a tissue.

First claim

Opening claim text (preview).

1 . A method for the prevention or treatment of a disorder associated with an above-normal number of granulocytes in a tissue comprising administering a composition comprising at least one cocoa polyphenol and at least one fermentable dietary fiber to an individual in need of same. 2 . Method according to claim 1 , wherein the disorder associated with an above-normal number of granulocytes in a tissue is selected from the group consisting of an eosinophilic gastrointestinal disorder, an allergy, a gastrointestinal syndrome, allergy associated with aeroallergen including asthma and allergic rhinithis, lung allergic inflammation and skin atopic dermatitis. 3 - 4 . (canceled) 5 . Method according to claim 1 , wherein the soluble dietary fiber is selected from the group consisting of pectin, beta-glucan, inulin, fructo- or galacto-oligosaccharides, pectin, alginic acids, fructans like inulin, raffinose, xylose, polydextrose, lactulose, Acacia gum, Guar Gum milk-derived oligosaccharides, and hydrolyzed fiber. 6 . Method according to claim 1 , wherein the composition comprises 2 to 80% (w/w) fermentable dietary fiber. 7 . Method according to claim 1 , further comprising a source of protein. 8 . Method according to claim 7 , wherein the protein is selected from the group consisting of potato protein, rice protein, legumes proteins, millet, quinoa, lupin, canola, tapioca, and combinations thereof. 9 . (canceled) 10 . Method according to claim 1 comprising a procyanidin selected from the group consisting of procyanidin B 1, procyanidin B2, a procyanidin not being procyanidin B1 or B2, one or more multimers of procyanidin B 1, procyanidin B2 or the procyanidins not being B1 or B2, the multimer being any of a 2-mer to a 10-mer; combinations thereof. 11 . Method according to claim 1 , wherein the composition comprises 0.01% to 0.5% (w/w) procyanidin B1 or multimers of the procyanidin. 12 . Method according to claim 1 , wherein the composition comprises 0.01% to 1.0% (w/w) procyanidin B2 or multimers of the procyanidin. 13 . Method according to claim 1 , wherein the composition comprises 0.5% to 10% (w/w) of procyanidins not being either procyanidin B1 or B2 or multimers of the procyanidins. 14 . Method according to claim 1 , wherein the composition comprises 0.01% to 0.5% (w/w) epicathequin. 15 . Method according to claim 1 , wherein the cocoa polyphenols are comprised in a plant extract or a concentrate. 16 . Method according to claim 1 , wherein the composition is to be administered orally, topical-orally, or in the form of a spray. 17 . Method according to claim 1 , wherein the composition is to be administered to a human being or a pet animal. 18 . (canceled) 19 . Method according to claim 1 , wherein the composition is in a form selected from the group consisting of a nutritional composition, an oral nutritional supplement provided as sole source of nutrition or as partial nutrition, complete or incomplete nutrition and a pharmaceutical product. 20 . Method according to claim 1 , having a caloric density of 0.5-3.0 kcal/ml. 21 . Method according to claim 1 comprising 10-40 en % protein, 10-60 en % carbohydrates, and 20-80 en % fat. 22 . Method according to claim 1 , wherein the fat is selected from the group consisting of fish oil, vegetable oil, medium chain triglycerides and mixtures thereof. 23 . Method according to claim 1 , wherein the composition comprises fat and 0-70 wt. %, of the fat are medium chain triglycerides. 24 . Method according to claim 1 , wherein the composition comprises carbohydrates and the carbohydrates are selected from a source selected from the group consisting of maltodextrin, starch, lactose, modified carbohydrates, sugar alcohols, high potency sweeteners and combinations thereof. 25 - 26 . (canceled)

Assignees

Inventors

Classifications

  • A61K31/353Primary

    3,4-Dihydrobenzopyrans, e.g. chroman, catechin · CPC title

  • Theobroma, e.g. cocao or cocoa · CPC title

  • Addition of substantially indigestible substances, e.g. dietary fibres · CPC title

  • Magnoliopsida (dicotyledons) · CPC title

  • Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2019008824A1 cover?
The present invention relates to a composition comprising at least one cocoa polyphenol and soluble dietary fiber for use in the prevention or treatment of a disorder associated with an above-normal number of granulocytes in a tissue.
Who is the assignee on this patent?
Nestec Sa
What technology area does this patent fall under?
Primary CPC classification A61K31/353. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jan 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).